Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Basic Trial Information
|No phase specified||Tissue collection/Repository||Active||Pediatric||NCI, Other||ACNS02B3|
NCI-2009-00334, COG-ACNS02B3, CDR0000352347, U10CA098543, NCT00919750
The purpose of this study is to collect and store brain tissue samples and blood from children with brain cancer that will be tested in the laboratory. Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.
Further Study Information
I. Collect brain tumor tissue and an accompanying blood sample from pediatric patients with brain tumors treated at Children's Oncology Group institutions.
II. Provide a repository for long-term storage of specimens from these patients.
III. Make these specimens available to qualified researchers to understand the biology of pediatric brain tumors.
OUTLINE: This is a multicenter study.
Brain tumor tissue and blood specimens are collected from patients and banked for future study.
- Diagnosis of brain tumor
- Previously treated at a Children's Oncology Group (COG) institution
- Patients are eligible at time of diagnosis, second-look surgery, recurrence, or development of a second malignant neoplasm
- Must have brain tumor biological specimens derived from primary tumors of the CNS available for submission
Trial Contact Information
Trial Lead Organizations/Sponsors
Children's Oncology Group
- National Cancer Institute
Saint Peter's University Hospital
Link to the current ClinicalTrials.gov record.
NLM Identifier NCT00919750
ClinicalTrials.gov processed this data on May 26, 2015
Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.